As a member of human tissue kallikrein family, Kallikrein 11, also known as hippostasin, trypsin-like serine protease and PRSS20, is encoded by the KLK11 gene (1). Two alternatively spliced forms exist, resulting in 250 (isoform 1) and 282 (isoform 2) amino acid sequences,respectively (2-5). Isoform 1 consists of a signal peptide (residues 1-18), a short pro peptide (residues 19-21) and the mature chain (residues 22-250). Isoform 2 is identical to isoform 1, except that a 32 amino acid segment is inserted in isoform 2 before residue 1 in isoform 1. Isoform 1 is predominantly expressed in brain whereas isoform 2 is preferentially expressed in prostate. KLK11 is a novel marker for ovarian and prostate cancer carcinomas (6-8). Recombinant human KLK11, after being activated by thermolysin, is active against a thioester substrate. This activity can be inhibited by AEBSF (Catalog # http://www.rndsystems.com/product_results.aspx?k=EI001">EI001), dichloroisocoumarin, and aprotinin. Recombinant human KLK11 produced by R&D Systems corresponds to isoform 1.
Recombinant Human Kallikrein 11 Protein, CF
R&D Systems | Catalog # 1595-SE
Key Product Details
- R&D Systems NS0-derived Recombinant Human Kallikrein 11 Protein (1595-SE)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
Accession Number
Structure / Form
Applications
Product Specifications
Source
Glu19-Asn250, with an N-terminal signal peptide and a C-terminal 10-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The specific activity is >200 pmol/min/µg, as measured under the described conditions.
Formulation, Preparation, and Storage
1595-SE
| Formulation | Supplied as a 0.2 μm filtered solution in Tris, NaCl and CaCl2. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Kallikrein 11
References
- Yousef, G.M. and E.P. Diamandis (2001) Endocrine Rev. 22:184.
- Yoshida, S. et al. (1998) Biochim. Biophys. Acta 1399:225.
- Yousef, G.M. et al. (2000) Genomics 63:88.
- Mitsui, S. et al. (2000) Biochem. Biophys. Res. Commun. 272:205.
- Gan, L. et al. (2000) Gene 257:119.
- Diamandis, E.P. et al. (2002) Cancer Res. 62:295.
- Nakamura, T. et al. (2003) Urology 61:1042.
- Borgono, C.A. et al. (2003) Int. J. Cancer 106:605.
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional Kallikrein 11 Products
Product Documents for Recombinant Human Kallikrein 11 Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Human Kallikrein 11 Protein, CF
For research use only
Related Research Areas
Citations for Recombinant Human Kallikrein 11 Protein, CF
Customer Reviews for Recombinant Human Kallikrein 11 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Kallikrein 11 Protein, CF and earn rewards!
Have you used Recombinant Human Kallikrein 11 Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Human Kallikrein 11 Protein, CF (1595-SE):
- Activation Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, pH 7.5 (TCN)
- Assay Buffer: 50 mM Tris, 1 M NaCl, 10 mM EDTA, pH 8.5
- Recombinant Human Kallikrein 11 (rhKLK11) (Catalog # 1595-SE)
- Bacterial Thermolysin (Thermolysin) (Catalog # 3097-ZN)
- EDTA (Sigma, Catalog # E-4884)
- Fluorogenic Peptide Substrate: Z-Lys-SBzl (Bachem, Catalog # M-1300), 10 mM stock in DMSO
- 5,5’-dithio-bis (2-nitrobenzoic acid) (DTNB) (Sigma, Catalog # D-8130), 10 mM stock in DMSO
- 96-well Clear Plate (Costar, Catalog # 92592)
- Plate reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
- Dilute rhKLK11 to 200 µg/mL in Activation Buffer.
- Dilute Thermolysin to 20 μg/mL in Activation Buffer.
- Combine equal volumes of 200 µg/mL rhKLK11 and 20 µg/mL Thermolysin.
- Incubate at 37 °C for 15 minutes.
- Stop Thermolysin activity by adding EDTA to a final concentration of 10 mM.
- Dilute incubated rhKLK11 to 2 ng/µL in Assay Buffer.
- Prepare Substrate Mixture containing 600 μM Substrate and 200 μM DTNB in Assay Buffer.
- Load into a clear plate 50 µL of the 2 ng/µL rhKLK11, and start the reaction by adding 50 µL of Substrate Mixture. Include a Substrate Blank containing 50 µL Assay Buffer and 50 µL of Substrate Mixture.
- Read at a wavelength of 405 nm (bottom read) in kinetic mode for 5 minutes.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (OD/min) x well volume (L) x 1012 pmol/mol |
| ext. coeff** (M-1cm-1) x path corr.*** (cm) x amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Using the extinction coefficient 13260 M-1cm-1
***Using the path correction 0.320 cm
Note: the output of many spectrophotometers is in mOD Per Well:
- rhKLK11: 0.1 µg
- Substrate: 300 µM
- DTNB: 100 µM